Maria E. Cabanillas, M.D. is an Oncologic Endocrinologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. She is a tenured Professor and the Faculty Director of Clinical Research in the department of Endocrine Neoplasia at MD Anderson.
As a clinician and clinical researcher, she treats both early and advanced thyroid cancers, including medullary, differentiated, and anaplastic thyroid cancers. Her research focus is in advanced and aggressive thyroid cancer, with an emphasis that includes molecular targeted therapies and immunotherapy. Dr. Cabanillas led the effort to create FAST, Facilitating Anaplastic thyroid cancer Specialized Treatment at MD Anderson. This multidisciplinary group sees the highest volume of anaplastic thyroid cancer patients in the nation. They have focused their efforts on streamlining the process to see these complex patients, tailor treatment plans based on the molecular abnormalities in the tumor, and designing clinical trials for this patient population.
Dr. Cabanillas serves as the principal investigator on several clinical trials for the treatment of advanced thyroid cancer and is an IRB vice-chair at MD Anderson. She has been a member of the International Thyroid Oncology Group (ITOG) since 2012 and currently serves on the Board of Directors.
